Stocks

The regulator has proposed shifting to a uniform quarterly reassessment to simplify the process and ensure consistency across entities

Cuts AUM growth guidance to 22-23% for FY26

Beyond Meat's stock opened at around $0.6 on October 16 and surged to about $7.4 on October 22, marking a 1,067 per cent jump in five sessions

Given bed additions in FY26, investors may focus on ramp-ups of newly launched facilities to gauge demand, competitive intensity, and earnings trends over the next two years

Power stocks, down over 22 per cent in the past year, may see renewed interest in H2FY26 as demand recovers, coal capacity expands and renewable additions accelerate

Capital markets regulator Sebi on Tuesday proposed the introduction of a standard reason code to streamline the transfer of securities from nominees to legal heirs and ensure appropriate tax treatment for such transactions. In a consultation paper, Sebi suggested introducing a specific reason code 'TLH' (Transmission to Legal Heirs) to be used by registrars, depositories and other reporting entities while intimating the Central Board of Direct Taxes about such transmissions. The move seeks to enable proper application of the provisions of the Income Tax Act, 1961. Currently, transmission of securities from nominee to legal heir of the original holder, some transactions are being treated as normal sale of securities. This has resulted in capital gains tax being levied on nominees, even though clause (iii) of Section 47 of the Act does not consider such transmissions as "transfers" for tax purposes, Sebi said. The regulator noted that the nominee merely acts as a trustee for the ben

In premarket trading, Albemarle Corp jumped nearly 9 per cent, while Chile's Sociedad Quimica y Minera rose 6.5 per cent and Lithium Americas gained nearly 9 per cent

The biopharma company's revenue from operations for the quarter ended June 30, 2025, surged 15 per cent year-on-year (Y-o-Y) to ₹3,942 crore, as compared to ₹3,433 crore reported in Q1FY25.

Broader markets witnessed a steeper decline. The Nifty Midcap 100 was trading 0.86 per cent lower, quoting 56,449 levels. Nifty Smallcap, meanwhile, was trading at 17,594, down by 0.56 per cent.

The company reported a 40 per cent rise in its profit after tax (PAT) figure to ₹589.27 crore during the quarter ended June 30, 2025, as against ₹419.8 crore reported in Q1FY25

The integrated steel company reported a 1 per cent year-on-year (Y-o-Y) decline to ₹1,323 crore during the quarter ended June 30, 2025

The pharma company's profit after tax (PAT) for the quarter ended June 30, 2025, stood at ₹215 crore, up 50 per cent from ₹143 crore reported in the corresponding quarter of the previous fiscal year.

The public issue was valued at ₹4,011.60 crore and consisted entirely of an offer for sale with shareholders offloading up to 50.1 million equity shares.

The buying interest on the counter came after the company announced that its joint venture (JV) with RBL Bank emerged as the lowest (L1) bidder for contract worth ₹1,503.63 crore

The company's earnings before interest, taxes, depreciation and amortization (Ebitda) stood at ₹414 crore during the quarter, down from ₹542 crore reported in the year-ago period

MCX reported a profit after tax (PAT) of ₹203.19 crore during the quarter ended June 30, 2025, up 83 per cent from ₹110.92 crore reported in the year ago period

The company's overall income for the quarter ended June 30, 2025, stood at ₹908 crore, as compared to ₹369 crore reported in the corresponding period of the previous fiscal year.

Majority of stocks from the Sensex pack were trading in red with Sun Pharma, Tata Steel, Tata Motors, Infosys and Tech Mahindra among the top laggards.

Stocks to buy: Motilal Oswal's research desk recommends HDFC Bank, Delhivery, Tata Consumer Products and others; check full list here

F&O stocks: For Apollo Hospitals, the short-term trend is positive as it is placed above its 5, 11 and 20-day EMA.